Introduction
============

High-grade sarcomas can be implanted into immunodeficient mice, where they grow as xenografts supported by the murine stroma blood supply \[[@ref1]\]. In general, transplantations of low-grade tumours fail to establish, with successful xenografts deriving mainly from aggressive neoplasms. Although some properties of the original tumours may not be fully represented, xenografts have become very useful models for preclinical experiments in cancer research \[[@ref2]--[@ref5]\].

In recent years, much research has focused on the role of angiogenesis in tumour development, growth, invasion, and metastasis \[[@ref6], [@ref7]\]. It has become clear that tumour angiogenesis is the result of an imbalance between proangiogenic and antiangiogenic factors, the threshold of change in favour of proangiogenesis is considered to be the angiogenic switch. Several angiogenic factors and chemokines related with angiogenic mechanisms have been studied in different tumour types \[[@ref6], [@ref8], [@ref9]\]. We recently communicated these findings in a nude mice osteosarcoma model \[[@ref10]\] as well as in two high-grade chondrosarcomas (in press) \[[@ref11]\]. The angiogenic process presents two different phases of tumour growth. An initial induction phase, in which new unstable vessels are built, followed by a remodelling phase, in which blood vessels are stabilised \[[@ref12]\]. At this point, hypoxia occurs and the angiogenic process is activated through the well-known hypoxia-inducible transcription factors (HIF) that induce the expression of several tumour-derived cytokines, such as vascular endothelial growth factors (VEGF) or fibroblast growth factors (FGF) \[[@ref6]\] and some chemokines (GRO, CXCL9, and CXCL10) with their respective receptors (CXCR2 and CXCR3) \[[@ref8], [@ref13], [@ref14]\]. More recently, the CXCL12/CXCR4 axis was reported to be involved in mediating tumour cell invasion and proliferation and to play an important role in tumour angiogenesis, progression, and metastasis \[[@ref15], [@ref16]\]. Moreover, CXCR4 expression has been associated with poor survival in bone and soft-tissue sarcomas \[[@ref17], [@ref18]\] and many types of carcinomas \[[@ref19]\]. Consequently, considerable interest has been generated in the therapeutic potential of targeting the growth of new vessels (antiangiogenesis) and the capacity to control those that have already been formed (vascular targeting) \[[@ref13], [@ref20]\].

Soft-tissue sarcomas are an infrequent group of mesenchymal tumours, they may be high grade and display poor survival \[[@ref21]\]. Gastrointestinal stromal tumour (GIST) is the most common primary mesenchymal tumour of the gastrointestinal tract and spans a clinical spectrum from benign to malignant; most cases contain *KIT*- or *PDGFRA*-activating mutations \[[@ref22]\]. Mutations in different genes may also be present, \[[@ref23]\] although the main prognostic factors are tumour size, mitotic activity, location and capsular invasion \[[@ref24], [@ref25]\]. Targeted therapy with imatinib is indicated for high-risk cases and in advanced disease \[[@ref23]\].

Synovial sarcoma (SS) is a mesenchymal tumour with a variable degree of epithelial differentiation and a specific chromosomal translocation t(X;18)(p11;q11) that leads to the formation of an *SS18--SSX* fusion gene. The differential diagnosis with a high-grade GIST may be difficult \[[@ref26], [@ref27]\]. Both tumour types cause metastasis and display an aggressive behaviour, suggesting that molecular reorganisations such as of *SYT--SSX* gene translocation and *KIT* mutations might be similarly essential for the growth of angiogenic factors. A recent publication described an intra-abdominal monophasic spindle cell SS that mimicked the morphology and immunohistochemistry of a high-risk spindle cell GIST \[[@ref27]\].

Several animal models have been used in the study of tumour angiogenesis \[[@ref12], [@ref14], [@ref28]\]. Studying angiogenesis through a xenograft model in high-grade sarcomas such as high-risk GIST and synovial sarcomas (SS) may provide a better understanding of this process and increase information regarding potential candidates for effective targeted therapy.

We developed a xenograft nude mice model to clarify the presence of angiogenic factors within the neoformed peritumoral stroma and in the internal tumour blood supply, during the early stages of tumour growth after the transfer into the subcutaneous tissue of the host. To this end, we used two previously established xenotransplanted tumour cell lines of human sarcomas: a high-risk spindle cell GIST and a monophasic spindle cell SS \[[@ref22], [@ref29]\].

Our aim was to characterise the markers associated with vasculogenesis using histology, immunohistochemistry, and molecular techniques and to search for similarities that may exist between the two tumours.

Materials and methods
=====================

Samples
-------

Samples were collected from patients treated at the Hospital Clínic Universitari de Valencia. The GIST came from a 63-year-old male with a gastric mass of approximately 26 × 20 × 35 cm diagnosed as a high-risk spindle cell tumour ([Figure 2A](#figure2){ref-type="fig"}). Firstly, the GIST was treated with imatinib (400 mg/day) for six months. The tumour responded partially to targeted therapy and finally resection of the mass was decided upon seven months after diagnosis. No metastasis was seen at the moment of diagnosis, but the patient died of various surgical complications after resection.

The SS came from a 32-year-old male who attended our hospital with a relapse in the right thigh and multiple lung metastases after chemo-radiotherapy. The tumour was approximately 10 × 8 × 8 cm and was diagnosed as monophasic spindle-cell SS, the patient died of tumour progression several months after diagnosis.

Molecular biology studies revealed genomic alterations in both tumours. The GIST had the *KIT* gene mutation and the SS had the typical translocation t(X,18)(*SYT-SSX*).

The tumours were collected for histopathological, ultrastructural, and genetic characterisation at our Pathology Department. The original tumours were transferred subcutaneously on the backs of nude mice (Nu407 and Nu335) and maintained for several generations (passages). In both tumours, we divided the passages into three time periods, early passages (from 1st to 5th passage), middle passages (from 6th to 10th passage) and late passages (from 11th to 15th passage). We calculated the average speed of tumour growth in both nude mice passages (Nu335 and Nu407) according to the formula (15 mm/days to next passage), 15 mm being the approximate tumour size when mice were sacrificed.

Tumour pieces 3--4 mm in size from the early passages of Nu407 and Nu335 were also xenografted subcutaneously on the backs of two sets of athymic Balb-c nude mice (*n* = 14 each). The animals were sacrificed at 24, 48, and 96 h; and 7, 14, 21, and 28 days after implantation (neovascularisation experiments). Tissue samples were fixed in 10% formaldehyde, paraffin-embedded, and haematoxylin and eosin (H&E) staining was performed for histological analysis. Moreover non-fixed samples were collected for molecular analysis. Approval for animal experimentation was obtained from the Ethics Committee of the Universitat de València Estudi General (UVEG).

Assembly of TMAs
----------------

Tissue microarrays were constructed using a Manual Tissue Arrayer (Beecher Instruments, Sun Praire, WI). Two cores (1 mm thick) of each sample were included, with additional cores in cases with diverse morphologic areas. The TMA contained normal tissue controls, original tumour, and the corresponding xenograft passages. The cores were grouped into early transfers 1--5, middle passages 6--10, and late passages 11--15. After assembly, an initial section from each TMA was stained with haematoxylin--eosin to evaluate the viability of the samples. Several 5-mm sections were also prepared for immunohistochemical (IHC) staining. [Table 1](#table1){ref-type="table"} summarises the antibodies used for the IHC.

Immunohistochemistry
--------------------

IHC was carried out by an indirect peroxidase method on paraffin sections following the same methodology, as we discussed in our previous papers \[[@ref10]\] and \[[@ref11]\].

Molecular biology
-----------------

RNA was extracted from 50 to 200 mg of tumour samples obtained from the NU335 and Nu407 series.

The whole methodology and studied genes ([Table 1S](#table1s){ref-type="table"}) are also discussed in our previous papers \[[@ref10]\] and \[[@ref11]\].

Results
=======

Histological, immunohistochemical and ultrastructural characterisation
----------------------------------------------------------------------

Comparing speed of growth in murine passages, we observed a similar average growth speed in SS (0.142 mm/day) and in GIST (0.103 mm/day)([Figure 1](#figure1){ref-type="fig"}).

TMAs
----

No morphological changes were observed between passages in GIST; however, a high number of mitoses were clearly observed in the passages in both tumours ([Figures 2B](#figure2){ref-type="fig"} and [2F](#figure2){ref-type="fig"}). The IHC study of GIST showed intense expression of vimentin, CD117, DOG1, desmin, and CD34 ([Figures 2C](#figure2){ref-type="fig"} and [2D](#figure2){ref-type="fig"}) and was negative for PDGFRα and S-100. Ki67 was expressed in 15% of tumour cells in all cores ([Figure 2E](#figure2){ref-type="fig"}).

The IHC study of SS showed positivity for EMA ([Figure 2G](#figure2){ref-type="fig"}), cytokeratin (AE1/AE3) and bcl-2. Intense positivity was also revealed for vimentin and weak expression for TLE1 in all passages. Ki67 increased slightly over the passages, being positive in 20% of tumour cells in the last passages ([Figure 2H](#figure2){ref-type="fig"}), whereas with GIST it was more constant.

Double-immunofluorescence staining demonstrated that chemokine ligand expression in general was slightly higher in the xenograft passages than in the original tumour ([Figure 3](#figure3){ref-type="fig"}). There were very few differences between the two sarcomas with regard to chemokine expression profile. CXCL10 was constantly high in both tumours and GRO was mildly expressed in all passages ([Figures 4A](#figure4){ref-type="fig"}, [4D](#figure4){ref-type="fig"}, and [4E](#figure4){ref-type="fig"}). CXCL9 increased in both tumours over the passages ([Figure 4B](#figure4){ref-type="fig"}). Their receptors CXCR2 and CXCR3 were constantly expressed in all passages, with CXCR2 presenting a higher expression in SS. Finally, the CXCL12/CXCR4 axis was constantly overexpressed in all passages in both tumours ([Figures 4C](#figure4){ref-type="fig"} and [4F](#figure4){ref-type="fig"}).

Neovascularisation experiments
------------------------------

In our neovascularisation experiments, during the first hours after xenografting, peritumoral haemorrhagic areas with inflammatory infiltration compounded by lymphocytes, plasma cells, neutrophils, karyorrhectic, and apoptotic figures were observed in SS and GIST. Small capillaries surrounded the xenograft associated with mesenchymal angioblastic and non-angioblastic cells included in a loose matrix.

Patchy hypoxic necrosis in SS appeared within the first 96 h after implantation, reaching a peak extension in the third week. The SS presented characteristic adipose tissue infiltrate and peritumoral skeletal muscle mouse fibres, but without the pseudocapsule observed in GIST. In GIST, the massive necrosis appeared during the first week, earlier than in the SS. After the fourth week, the histological picture of the GIST was re-established, with features similar to those of the human control, re-establishing also the amount of mitoses and the remission of necrosis, which became patchy and scant. During the third week after xenografting, the inflammatory component decreased. At this time, newly formed capillary vessels were remodelled and penetrated or sprouted into the tumour.

Areas of massive necrosis were associated with a lower proliferative index in both tumours. Ki67 was lower in the early stages after tumour xenografting in both tumours. In the last weeks, the increase in Ki67 expression was also inversely correlated with HIF1α in both neoplasms.

Angiogenic factors represented by the VEGF family and their receptors presented a different expression profile in the two tumours. In SS, maximum VEGF positivity presented 24 h after implantation and was also expressed in the extracellular matrix, while VEGF positivity was lower in GIST and appeared 96 h after xenografting ([Figure 2I](#figure2){ref-type="fig"}). VEGFR2 presented a similar expression profile to its ligand, and VEGFR3 was the most positive receptor in both tumours. HIF1α expression was slightly higher and more constitutively expressed in SS than GIST

Double-immunofluorescence staining showed chemokine expression (CXCL9, CXCL10 and GRO) in the tumour cell cytoplasm/nucleus and deposited in the extracellular matrix. This was also the case for their receptors (CXCR3 and CXCR2) ([Figures 4G](#figure4){ref-type="fig"} and [4H](#figure4){ref-type="fig"}). Chemokine ligand expression was higher during the first 48 h in GIST; however, it appeared later in SS where peak expression occurred during the first week. The CXCL12/CXCR4 axis showed an intense coexpression in both sarcomas at all times throughout the experience. Interestingly, we observed that murine peritumoral stroma expressed CXCR4 but not CXCL12 in the two tumour xenografts ([Figure 4I](#figure4){ref-type="fig"}). It is worth mentioning that the chemokine receptors were expressed more constantly at all times in comparison with their ligands.

qRT-PCR low-density arrays of angiogenesis-related genes
--------------------------------------------------------

Gene expression profiles ([Figure 5](#figure5){ref-type="fig"}) in GIST were similar at 24 h and 7 days but differed from those observed at 48 h, 14 and 21 days. However, SS expression profiles were similar at 24 h and 28 days, differing from those at 48 h and 14 days. In GIST, the early phase appeared 96 h after xenografting and was characterised by the overexpression of genes clearly involved in angiogenesis induction, including VEGF, PDGFA, PDGFB, VEGFC, and their receptors. In contrast, the earlier phase in SS occurred during the first week after xenografting. Finally, in GIST, the late phase of the angiogenic process (remodelling phase) appeared during the first week after xenografting, while in SS, this phase appeared later in the fourth week.

RNA samples corresponding to the third week of SS and to the fourth week of GIST were not viable for analysis.

Discussion
==========

Angiogenesis is critical for the growth and metastasis of tumours. Early in tumorigenesis, an angiogenic switch is activated by hypoxia, promoting the expression of pro-angiogenic growth factors, such as the VEGF family, its receptors, and HIF1α among others \[[@ref7]\]. Recent publications have highlighted the difficulties in differentiating between GIST and monophasic intra-abdominal SS, where molecular mutations are sometimes the only distinguishing feature \[[@ref27]\]. It has been suggested that it would be particularly informative to explore possible relationships between the presence of vasculogenic structures and the response to antiangiogenesis therapy \[[@ref30], [@ref31]\]. Furthermore, it is interesting to speculate that antiangiogenic therapy may result in a selective growth advantage for cells exhibiting vasculogenic mimicry and vascular co-option, promoting drug-induced resistance \[[@ref30], [@ref31]\].

HIF1α is a principal regulator of cellular and systemic homeostatic response to hypoxia as it activates many genes, including those involved in angiogenesis \[[@ref6]\]. In our model, HIF1α was overexpressed in the early stages, indicating that the angiogenic process is constitutively active in the xenotransplanted tumour. HIF1α plays an important role in angiogenic induction and remodelling phases and in an increased VEGF expression \[[@ref32]\]. Some recent studies of GIST and chondrosarcoma have shown a correlation between the expression of angiogenic markers, such as VEGF and microvessel density, and a worse prognosis \[[@ref33], [@ref34]\], suggesting that the development of antiangiogenic chemotherapy might be useful. However, in other tumours, such as osteosarcoma, microvessel density seems to be associated with a longer overall and relapse-free survival \[[@ref34], [@ref35]\]. Imatinib continues to be used as a first-line medical treatment for advanced GIST, although resistance and non-response sometimes appear. Sunitinib and regorafenib, antiangiogenic drugs, are used as second- and third-line therapies, respectively, and are given in imatinib-resistant GIST cases \[[@ref23]\]. Volumetric growth and the development of metastases in cases of GIST appear to be related to the development of a new vascular network \[[@ref36]\]. The importance of vascularisation in the context of GIST is the action mechanism of the second-generation drug sunitinib, which is based on the blockade of VEGF activity along with tyrosine kinase receptor blockade that has been used with success in some GIST patients \[[@ref37], [@ref38]\].

Anthracyclines and ifosfamide, either alone or in combination, are the gold standard treatments for advanced SS \[[@ref39]\]. However, after failure of conventional first-line cytotoxic chemotherapy, available treatment options are severely limited because of a high risk-to-benefit ratio in terms of patient tolerability and survival. Recently, it has been demonstrated that pazopanib is a feasible option for patients who have been heavily pre-treated for metastatic SS \[[@ref40]\].

Cluster analysis performed on our qRT-PCR expression studies revealed two additional groups of genes clearly separated into two stages, corresponding to early angiogenic induction where VEGF and PDGF family genes among others play an important role, and the later remodelling phases where other angiogenic genes are overexpressed. Apparently the high-risk GIST behaved biologically as high-grade sarcoma in the passages and neovascularisation experiments similar to our previous molecular results \[[@ref10]\]. However, induction and remodelling phases of SS appeared later than GIST and other high-grade bone tumours \[[@ref10]\]. This difference may be related to a different sensibility and response to antiangiogenic drugs, with GIST being more sensitive. Nevertheless, we cannot be sure that this difference will have any biological translation.

In addition to angiogenic factors, chemokines also play an important role during angiogenic induction. The coexpression of ligands and chemokine receptors in neoplastic cells and extracellular matrix suggests that autocrine and paracrine stimulation by the tumour cells results in production of angiogenic factors in response to hypoxia during the first stages of tumour growth, as reported in other neoplastic and non-neoplastic conditions \[[@ref8], [@ref12], [@ref30], [@ref41]\]. Moreover, we found a correlation between high chemokine ligand expression and hypoxic necrosis in both tumours. Few studies of chemokines in SS and GIST have been made \[[@ref42], [@ref43]\]. CXCR4 expression has been related with poor prognosis in patients with bone and soft-tissue sarcomas in a meta-analysis \[[@ref17]\]. High expression of CXCL12/CXCR4 was observed in all passages of both tumours and in the neovascularisation experiment, this could be related with their aggressive clinical behaviour. The CXCL12/CXCR4 axis is related to mediating tumour cell invasion and proliferation and plays an important role in tumour angiogenesis, progression and metastasis \[[@ref44]\]. CXCL12/CXCR4 is overexpressed by tumour cells, but not by murine stromal peritumoral cells which only produce CXCR4. Perhaps CXCL12 induces murine stromal cells to generate new vessels in a paracrine effect and may be a good objective for targeted therapy to reduce tumour growth.

Conclusions
===========

This model provides information on the early stages of the angiogenic process in monophasic spindle-cell SS and high-risk GIST. We suggest that different angiogenic molecular profiles could predict different biological and clinical behaviour and determine the response to antiangiogenic treatment. We also demonstrate the importance of chemokine expression as a therapeutic target of tumour growth.

The fact that angiogenesis is a dynamic, changing and multistep process over time should be taken into consideration when developing future therapeutic strategies in soft-tissue tumours.
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![Graphics of speed of growth in both tumours throughout the passages in nude mice.](can-11-726fig1){#figure1}

![(A) GIST with spindle-cell pattern (H&E, 20X). (B) High-risk GIST with some mitotic figures (H&E, 40X). (C) Intense positivity of DOG-1 in GIST, 40X. (D) Intense positivity of CD34 in GIST, 40X. (E) High proliferative Ki67 index in late passages of GIST, 40X. (F) Monomorphic spindle-cell pattern in SS (H&E, 40X). (G) Mild EMA positivity in SS, 40X. (H) High proliferative Ki67 index in late passages of SS, 40X. (I) Intense VEGF expression in SS 24 h after tumour implantation, 40X.](can-11-726fig2){#figure2}

![Graphics of chemokine ligand and receptor expression in both tumours throughout the passages in nude mice.](can-11-726fig3){#figure3}

![Immunofluorescent expression of chemokines and their receptors in GIST and SS throughout the early, middle, and late passages and in the neovascularisation experiment. (A) Double-immunofluorescence staining shows coexpression of chemokine ligand CXCL10 (red) and its receptor CXCR3 (green) in GIST tumour cells in early passages (40X). (B) Immunofluorescence staining shows expression of chemokine ligand CXCL9 (red) in GIST tumour cells in later passages (40X). (C) double-immunofluorescence staining shows coexpression of chemokine ligand CXCL12 (green) and its receptor CXCR4 (red) in GIST tumour cells in middle passages (40X). (D) Immunofluorescence staining shows expression of chemokine ligand GRO (red) in SS tumour cells in middle passages (40X). (E) double-immunofluorescence staining shows coexpression of chemokine ligand CXCL10 (red) and its receptor CXCR3 (green) in SS tumour cells in late passages (40X). (F) Double-immunofluorescence staining shows high coexpression of chemokine ligand CXCL12 (green) and its receptor CXCR4 (red) in SS tumour cells in late passages (40X). (G) Double-immunofluorescence staining shows coexpression of chemokine ligand GRO (red) and its receptor CXCR2 (green) in SS tumour cells 24 h after xenografting (40X). (H) Double-immunofluorescence staining shows coexpression of chemokine ligand GRO (red) and its receptor CXCR2 (green) in GIST tumour cells in the control tumour (40X). (I) Double-immunofluorescence staining shows coexpression of chemokine ligand CXCL12 (green) and its receptor CXCR4 (red) in GIST tumour cells two weeks after xenotransplantation (40X), observe the different expression between murine stroma (arrow) and tumour cells (asterisk).](can-11-726fig4){#figure4}

![Cluster tree of genes related to angiogenesis by qRT-PCR obtained from the Nu335 (SS) (A) and Nu407 (GIST) (B) series using distance correlation and applying a linear correlation coefficient at different times. Overexpressed genes are shown in dark red, underexpressed genes in dark blue and no change in white. Samples from third week in SS, and fourth week in GIST were not available for analysis ([Table 2S](#table2){ref-type="table"} and [3S](#table3){ref-type="table"}).](can-11-726fig5){#figure5}

###### Antibodies used in the experiences.

  Marker        Clonality (Clon)       Location             Dilution      Manufacturer
  ------------- ---------------------- -------------------- ------------- --------------
  Ki-67         Monoclonal (MIB-1)     Nuclear              1/50          Dako
  HIF1 α        Monoclonal (HI α 67)   Cytoplasm            1/500         Chemicon
  VEGF          Monoclonal (VG 1)      Cytoplasm            1/100         Neomarkers
  VEGFR1        Polyclonal (rabbit)    Cytoplasm/membrane   1/400         Santa Cruz
  VEGRF2        Polyclonal (rabbit)    Cytoplasm/membrane   1/400         Santa Cruz
  VEGFR3        Polyclonal (rabbit)    Cytoplasm/membrane   1/400         Santa Cruz
  PDGFR α       Polyclonal (rabbit)    Cytoplasm            1/100         Santa Cruz
  FGF 2         Polyclonal (rabbit)    Cytoplasm            1/200         Santa Cruz
  VE- CAD       Polyclonal (goat)      Cytoplasm/membrane   1/50          Santa Cruz
  CXCL9         Polyclonal (goat)      Cytoplasm            1/100         R&DSystems
  CXCL10        Polyclonal (goat)      Nuclear/cytoplasm    1/100         R&DSystems
  GRO           Monoclonal (31716)     Cytoplasm            1/200         R&DSystems
  CXCL12        Monoclonal(79018)      Cytoplasm            1/60          R&DSystems
  CXCR3         Monoclonal (2Ar1)      Cytoplasm/membrane   1/200         Abcam
  CXCR2         Polyclonal(mouse)      Cytoplasm/membrane   1/20          BioLegend
  CXCR4         Monoclonal(44716)      Nuclear              1/150         R&DSystems
  Vimentine     Monoclonal (V9)        Cytoplasm            1/300         Novocastra
  DOG-1         Monoclonal (BV10)      Cytoplasm            1/50          DBS
  CD117         Polyclonal (rabbit)    Membrane/cytoplasm   1/100         Dako
  TLE-1         Polyclonal (rabbit)    Nuclear              1/50          Santa Cruz
  CD34          Monoclonal (QBEnd10)   Cytoplasm            pre-diluted   Dako
  S-100         Polyclonal (rabbit)    Cytoplasm            1/2000        Dako
  Desmin        Monoclonal (D33)       Cytoplasm            pre-diluted   Dako
  EMA           Monoclonal (E29)       Cytoplasm/membrane   1/200         Dako
  CK(AE1/AE3)   Monoclonal (AE1/AE3)   Cytoplasm/membrane   1/100         Dako
  BCL-2         Monoclonal (3.1)       Nuclear              1/50          Novocastra

###### Supplementary. Genes and assays included in the low-density array for the study of the expression of angiogenic factors by quantitative RT-PCR.

  -----------------------------------------------------------------------------------------------------------------------------------------
  S.No                                            Gene symbol                          Assay references\      Amplicon size (pb)   OMIM
                                                                                       (Applied Biosystems)                        
  ----------------------------------------------- ------------------------------------ ---------------------- -------------------- --------
  1                                               *AMOT (angiomotin)*                  Hs00611096_m1          65                   300410

  2                                               *ANG (angiogenina)*                  Hs00265741_s1          91                   105850

  3                                               *ANGPT1 (angiopoietin-1)*            Hs00181613_m1          87                   601667

  4                                               *ANGPT2 (angiopoietin-2)*            Hs00169867_m1          73                   601922

  5                                               *CHGA (Vasostatin/Chromogranin-A)*   Hs00154441_m1          115                  118910

  **Growth factors and receptors**                                                                                                 

  6                                               *Ephrin 2A (EFNA2)*                  Hs00154858_m1          89                   602756

  7                                               *Ephrin-A5 (EFNA5)*                  Hs00157342_m1          98                   601535

  8                                               *Ephrin-B2 (EFNB2)*                  Hs00187950_m1          63                   600527

  9                                               *EPHB4 (Ephrin B4)*                  Hs00174752_m1          82                   600011

  10                                              *FGF1 (aFGF)*                        Hs00265254_m1          65                   131220

  11                                              *FGF2 (bFGF)*                        Hs00266645_m1          82                   134920

  12                                              *FGF4*                               Hs00173564_m1          53                   164980

  13                                              *FGF6*                               Hs00173934_m1          64                   134921

  14                                              *FGF7*                               Hs00384281_m1          85                   148180

  15                                              *FGFR1*                              Hs00241111_m1          81                   136350

  16                                              *FGFR2 (KGFR)*                       Hs00240792_m1          77                   176943

  17                                              *FGFR3*                              Hs00179829_m1          104                  134934

  18                                              *FGFR4*                              Hs00242558_m1          74                   134935

  19                                              *PDGFA*                              Hs00234994_m1          93                   173430

  20                                              *PDGFB*                              Hs00234042_m1          80                   190040

  21                                              *PDGFRA*                             Hs00183486_m1          92                   173490

  22                                              *PDGFRB*                             Hs00182163_m1          86                   173410

  23                                              *PF4 (Platelet factor 4)*            Hs00236998_m1          86                   173460

  24                                              *TGFA*                               Hs00177401_m1          95                   190170

  25                                              *TGFB1*                              Hs00171257_m1          63                   190180

  26                                              *TGFB2*                              Hs00234244_m1          92                   190220

  27                                              *TGFB3*                              Hs00234245_m1          75                   190230

  28                                              *TGFBR1*                             Hs00610319_m1          126                  190181

  29                                              *TGFBR2*                             Hs00234253_m1          70                   190182

  30                                              *TGFBR3*                             Hs00234257_m1          60                   600742

  31                                              *FIGF (VEGFD)*                       Hs00189521_m1          130                  300091

  32                                              *FLK1 (KDR)*                         Hs00176676_m1          84                   191306

  33                                              *FLT1 (VEGFR2)*                      Hs00176573_m1          55                   165070

  34                                              *PGF*                                Hs00182176_m1          56                   601121

  35                                              *VEGF*                               Hs00173626_m1          77                   192240

  36                                              *VEGFB*                              Hs00173634_m1          69                   601398

  37                                              *VEGFC*                              Hs00153458_m1          126                  601528

  38                                              *FLT4 (VEGFR3)*                      Hs01047679_m1          89                   136352

  39                                              *CD36*                               Hs00169627_m1          77                   173510

  40                                              *EDG1*                               Hs00173499_m1          102                  601974

  41                                              *EGF*                                Hs00153181_m1          95                   131530

  42                                              *EGFR*                               Hs00193306_m1          69                   131550

  43                                              *GRO1 (CXCL1)*                       Hs00236937_m1          70                   155730

  44                                              *HGF (Scatter factor)*               Hs00300159_m1          92                   142409

  45                                              *IGF1*                               Hs00153126_m1          70                   147440

  46                                              *IGF1R*                              Hs00181385_m1          77                   147370

  47                                              *TEK (Tie-2)*                        Hs00176096_m1          82                   600221

  48                                              *TIE1*                               Hs00178500_m1          74                   600222

  **Cytokines and chemokines**                                                                                                     

  49                                              *CSF3*                               Hs00236884_m1          78                   138970

  50                                              *IFNA1*                              Hs00256882_s1          115                  147660

  51                                              *IFNB1*                              Hs00277188_s1          134                  147640

  52                                              *IFNG*                               Hs00174143_m1          79                   147570

  53                                              *IL10*                               Hs00174086_m1          119                  124092

  54                                              *IL12A*                              Hs00168405_m1          67                   161560

  55                                              *IL8*                                Hs00174103_m1          101                  146930

  56                                              *MDK*                                Hs00171064_m1          102                  162096

  57                                              *NRP1 (neuropilin-1)*                Hs00826129_m1          97                   602069

  58                                              *PRL (prolactin)*                    Hs00168730_m1          76                   176760

  59                                              *PTN (pleiotrophin)*                 Hs00383235_m1          76                   162095

  60                                              *SCYA2*                              Hs00234140_m1          101                  158105

  61                                              *SPARC*                              Hs00277762_m1          122                  182120

  62                                              *TNFA*                               Hs00174128_m1          80                   191160

  63                                              *TNFSF15 (VEGI)*                     Hs00353710_s1          97                   604052

  **Adhesion molecules**                                                                                                           

  64                                              *CDH5 (VE-Cadherin)*                 Hs00174344_m1          66                   601120

  65                                              *ITGA5 (integrin a5)*                Hs00233743_m1          86                   135620

  66                                              *ITGAV (integrin aV)*                Hs00233808_m1          64                   193210

  67                                              *ITGB3*                              Hs00173978_m1          89                   173470

  68                                              *PECAM1 (CD31)*                      Hs00169777_m1          65                   173445

  **Matrix Proteins, Proteases and Inhibitors**                                                                                    

  69                                              *ADAMTS1 (METH1)*                    Hs00199608_m1          68                   605174

  70                                              *ADAMTS8 (METH2)*                    Hs00199836_m1          59                   605175

  71                                              *COL18A1 (LOC51695/endostatin)*      Hs00181017_m1          72                   120328

  72                                              *FN1 (fibronectin)*                  Hs00415006_m1          86                   135600

  73                                              *HPSE (heparanase)*                  Hs00180737_m1          59                   604724

  74                                              *MMP2*                               Hs00234422_m1          83                   120360

  75                                              *MMP9*                               Hs00234579_m1          54                   120361

  76                                              *MSR1*                               Hs00234012_m1          80                   153622

  77                                              *PLAU (uPA)*                         Hs00170182_m1          104                  191840

  78                                              *SERPINB5 (maspin)*                  Hs00184728_m1          104                  154790

  79                                              *SERPINF1 (PEDF)*                    Hs00171467_m1          88                   172860

  80                                              *THBS1*                              Hs00170236_m1          109                  188060

  81                                              *THBS2*                              Hs00170248_m1          87                   188061

  82                                              *THBS3*                              Hs00200157_m1          85                   188062

  83                                              *THBS4*                              Hs00170261_m1          98                   600715

  83                                              *TIMP1*                              Hs00171558_m1          104                  305370

  85                                              *TIMP2*                              Hs00234278_m1          73                   188825

  **Transcription factors**                                                                                                        

  86                                              *ERBB2*                              Hs00397754_m1          58                   164870

  87                                              *ETS1*                               Hs00428287_m1          92                   164720

  88                                              *HIF1A*                              Hs00153153_m1          76                   603348

  89                                              *ID1*                                Hs00357821_g1          62                   600349

  90                                              *ID3*                                Hs00171409_m1          129                  600277

  91                                              *MADH1 (SMAD1)*                      Hs00195432_m1          67                   601595

  **Other related genes**                                                                                                          

  92                                              *ENG (endoglin)*                     Hs00164438_m1          81                   131195

  93                                              *PTGS1 (cox-1)*                      Hs00168776_m1          109                  176805

  94                                              *PTGS2 (cox-2)*                      Hs00153133_m1          75                   600262

  95                                              *B2M (Housekeeping)*                 Hs99999907_m1          75                   109700

  96                                              *18S (Housekeeping)*                 Hs99999901_s1          187                  180473
  -----------------------------------------------------------------------------------------------------------------------------------------

###### Supplementary. 2-^DDCt^ values corresponding to the Nu335 series.

  Gene_Symbol                     24 h          48 h          96 h          1 week        2 week        3 week   4 week
  ------------------------------- ------------- ------------- ------------- ------------- ------------- -------- -------------
  **ADAMTS1-Hs00199608_m1**       0.7959605     0.03487536    2.2625384     1.1141776     0.010976258            1.7567259
  **AMOT-Hs00611096_m1**          0.26376235    0.05707947    0.37297338    0.5533971     5.48E-04               0.6260453
  **ANG;RNASE4-Hs00265741_s1**    8.801705      0.049484883   23.473007     7.5595713     0.015574286            2.9783483
  **ANGPT1-Hs00181613_m1**        0.009880596   0.05084049    1.1490225     1.854033      0.016000934            1.1941226
  **ANGPT2-Hs00169867_m1**        3.6326275     0.03473391    16.737255     10.326439     0.01093174             10.955148
  **CCL2-Hs00234140_m1**          2.683348      0.16359264    13.288964     2.8040843     0.05148721             1.0333282
  **CD36-Hs00169627_m1**          0.053531617   0.2754463     1.3808194     1.1198069     0.0866907              1.021473
  **CDH5-Hs00174344_m1**          0.31543005    0.1952118     1.5071367     3.5636954     0.06143865             0.7977747
  **CHGA-Hs00154441_m1**          NV            NV            NV            32.096264     NV                     4.5581665
  **COL18A1-Hs00181017_m1**       0.23082852    5.42E-04      0.277198      0.50039613    1.71E-04               1.3184813
  **CXCL1-Hs00236937_m1**         27.300922     NV            89.66844      32.197247     NV                     NV
  **EDG1-Hs00173499_m1**          0.059957597   0.006040307   1.2171141     0.56891876    0.001901055            0.5275882
  **EFNA2-Hs00154858_m1**         1.2024206     0.030415064   2.0298295     2.827156      0.009572477            5.3208594
  **EFNA5-Hs00157342_m1**         0.24109949    2.847728      0.9345426     1.2443724     0.58063984             2.1034224
  **EFNB2-Hs00187950_m1**         0.23342909    0.001960718   0.57025087    0.5076365     6.17E-04               0.87659615
  **EGF-Hs00153181_m1**           0.038981758   0.20058018    1.7117009     0.016707698   0.063128226            0.013953778
  **EGFR-Hs00193306_m1**          1.1801668     0.008366582   5.0673194     3.822592      0.002633199            5.079238
  **ENG-Hs00164438_m1**           0.20527008    0.016204517   0.41111425    0.6621962     0.005100017            0.94549626
  **EPHB4-Hs00174752_m1**         0.21828675    0.004649402   0.34418315    0.44173142    0.004203849            0.56949294
  **ERBB2;LEMD2-Hs00397754_m1**   0.46552873    0.00398609    0.5910703     0.673706      0.001254535            0.79151744
  **ETS1-Hs00428287_m1**          0.49607438    0.15065551    4.2109904     1.3082498     0.08166007             1.3172712
  **FGF1-Hs00265254_m1**          NV            41.08322      72.76203      120.863304    11.979111              26.906906
  **FGF2-Hs00266645_m1**          0.17037809    0.04496078    0.62800163    0.09589044    0.014150422            0.33385146
  **FGF7-Hs00384281_m1**          42.009033     89.45992      52.361824     112.07813     0.17391264             214.21053
  **FGFR1-Hs00241111_m1**         0.68052554    5.25E-04      2.3998103     1.0269998     1.65E-04               1.056858
  **FGFR2-Hs00240792_m1**         6.43E-04      0.003308094   5.33E-04      2.76E-04      0.019054554            2.30E-04
  **FGFR3-Hs00179829_m1**         0.47414583    0.010906449   0.5086395     0.9106528     0.003432566            0.87494045
  **FGFR4-Hs00242558_m1**         0.003453373   0.017769288   0.002865036   0.01827872    0.005592495            0.043755062
  **FIGF-Hs00189521_m1**          1.0680918     0.28433153    0.96531004    1.8435278     0.08948714             0.71032244
  **FLT1-Hs00176573_m1**          14.741555     0.31529078    18.3541       25.0587       0.099230886            66.39617
  **FLT4-Hs01047679_m1**          1.6021613     0.22230674    1.8908751     1.8908751     0.06996619             0.638229
  **FN1-Hs00415006_m1**           0.009271171   0.001936899   0.31474605    0.31758147    3.59E-05               0.38421825
  **HGF-Hs00300159_m1**           0.74494153    0.28053638    2.331105      2.4146729     0.088292696            6.643718
  **HIF1A-Hs00153153_m1**         5.79E-04      2.21E-04      0.002376824   1.50E-04      6.96E-05               1.54E-05
  **HPSE-Hs00180737_m1**          0.49950182    2.8662815     1.926133      2.6158357     2.3470185              3.2462463
  **ID1-Hs00357821_g1**           0.73769003    9.48E-04      2.9761086     2.6793191     2.98E-04               0.79354596
  **ID3-Hs00171409_m1**           0.31624177    0.004542778   3.55751       4.1943107     0.00142974             0.5460467
  **IFNA1-Hs00256882_s1**         17.625673     0.022310615   33.60883      2.8208911     0.0561009              0.001552084
  **IFNB1-Hs00277188_s1**         270.98575     10.319205     2313.754      2928.3418     0.08540048             1875.1154
  **IGF1-Hs00153126_m1**          0.8666961     0.050800312   2.1075785     0.8580654     0.015988288            0.26206714
  **IGF1R-Hs00181385_m1**         0.38215917    0.010849698   0.93247163    0.640436      0.003414705            0.7276512
  **IL10-Hs00174086_m1**          458.27228     NV            3026.768      2293.5767     NV                     2484.658
  **IL12A-Hs00168405_m1**         0.567523      0.22941716    0.98875076    0.84497744    0.07220404             1.0499607
  **IL8-Hs00174103_m1**           16.041344     0.13745503    85.10393      68.07324      0.043260965            86.558304
  **ITGA5-Hs00233743_m1**         0.04292659    0.004046804   0.22571458    0.5543176     0.001273643            0.6485964
  **ITGAV-Hs00233808_m1**         3.62E-04      0.001865129   0.005105441   0.001578465   5.87E-04               1.30E-04
  **ITGB3-Hs00173978_m1**         0.63354474    0.15661171    5.783896      0.8021871     0.049290113            0.25538987
  **KDR-Hs00176676_m1**           0.049058992   0.25243247    0.04070101    1.8342797     0.079447605            1.1495711
  **MDK-Hs00171064_m1**           5.30E-05      2.73E-04      4.40E-05      2.27E-05      8.59E-05               1.90E-05
  **MMP2-Hs00234422_m1**          0.19907643    1.38E-04      0.87531877    1.2991811     4.35E-05               1.2406509
  **MMP9-Hs00234579_m1**          2.7669928     0.17505844    7.6940885     5.5476108     0.055095818            4.2932944
  **NRP1-Hs00826129_m1**          0.12803793    7.99E-04      0.4838971     0.84648466    0.003289067            0.93841285
  **PDGFA-Hs00234994_m1**         0.4389812     0.002506821   0.8385384     0.43000203    7.89E-04               1.611485
  **PDGFB-Hs00234042_m1**         1.2534354     0.016952496   2.7536328     1.3462225     0.005335427            0.8673197
  **PDGFRA-Hs00183486_m1**        0.019641923   2.46E-04      0.037229206   0.003201435   7.74E-05               5.76E-04
  **PDGFRB-Hs00182163_m1**        0.26188913    0.035274055   1.1167214     2.384623      0.011101739            1.1476152
  **PGF-Hs00182176_m1**           2.9858983     0.024673844   7.7015076     5.086536      0.007765553            6.028427
  **PLAU-Hs00170182_m1**          1.1980854     0.27836916    1.982732      1.4934684     0.08761061             0.44911763
  **PRL-Hs00168730_m1**           0.106087364   0.54587126    2.3486202     0.04546936    0.17180106             0.4713016
  **PTGS1-Hs00168776_m1**         0.053466685   0.2751122     0.04435778    0.4627111     0.08658555             0.39559445
  **PTGS2-Hs00153133_m1**         345.7538      0.5678802     1413.4844     1064.7853     0.1787279              1878.3756
  **PTN-Hs00383235_m1**           0.18134442    0.007857767   0.64166147    1.232515      0.002473061            4.575156
  **SERPINF1-Hs00171467_m1**      0.073242776   2.50E-04      0.38210613    0.7587081     7.86E-05               2.3391302
  **SMAD1-Hs00195432_m1**         1.1732796     0.002044792   3.2746916     8.598647      6.44E-04               18.83404
  **SPARC-Hs00277762_m1**         0.1108581     0.001018303   0.63713557    0.6971213     2.43E-04               0.76808304
  **TEK-Hs00176096_m1**           0.68615204    0.10372496    0.37136102    0.4196441     0.032645162            0.68975556
  **TGFA-Hs00177401_m1**          0.007058851   4.596679      0.19149838    0.26590338    0.105379626            1.2052153
  **TGFB1-Hs00171257_m1**         0.10877489    0.004435655   1.9193434     1.6530409     0.001396026            1.7242657
  **TGFB2-Hs00234244_m1**         0.13737491    0.001103383   3.099895      3.3531804     3.47E-04               1.0426474
  **TGFB3-Hs00234245_m1**         0.15789403    0.00436108    1.0450748     1.0556368     0.001372555            0.9004825
  **TGFBR1-Hs00610319_m1**        0.09502458    0.004009001   2.2182114     1.4024074     0.001261745            1.632517
  **TGFBR2-Hs00234253_m1**        31.741417     14.806774     75.4627       98.78798      0.070976205            58.946075
  **TGFBR3-Hs00234257_m1**        0.0168747     0.002223517   0.10899068    0.1265091     7.00E-04               0.093545
  **THBS1-Hs00170236_m1**         0.02627843    0.013971536   0.05666908    0.07892739    0.004397236            0.080069
  **THBS2-Hs00170248_m1**         0.24877942    0.00247538    0.5332035     0.46211198    7.79E-04               0.99361634
  **THBS3-Hs00200157_m1**         0.057871778   0.010964321   0.81936586    1.063532      0.00345078             1.3852974
  **THBS4-Hs00170261_m1**         0.25605658    0.041287363   1.055909      2.2569547     0.012994295            1.6387945
  **TIE1-Hs00178500_m1**          14.531259     NV            NV            8.991988      NV                     5.8403964
  **TIMP1-Hs00171558_m1**         0.09594396    0.001097487   1.7285247     2.1242523     3.45E-04               2.5862403
  **TIMP2-Hs00234278_m1**         0.23860645    0.001554409   0.8069738     0.8414052     4.48E-05               0.7541748
  **TNFSF15-Hs00353710_s1**       8.819573      0.09758525    13.036365     1.5936899     0.030712826            0.28507906
  **VEGF-Hs00173626_m1**          10.268918     0.004262844   12.111028     4.5594625     0.001341637            0.90244776
  **VEGFB-Hs00173634_m1**         0.04733373    0.001347965   0.0785328     0.041420598   1.1771686              0.013903745
  **VEGFC-Hs00153458_m1**         85.88848      NV            130.90923     236.45436     NV                     379.6854

###### Supplementary. 2-^DDCt^ values corresponding to the Nu407 series.

  Gene_Symbol                     24 h          48 h          96 h          1 week        2 week        3 week        4 week
  ------------------------------- ------------- ------------- ------------- ------------- ------------- ------------- --------
  **ADAMTS1-Hs00199608_m1**       0.96953326    0.43141022    2.2340128     0.7876811     0.40883076    1.062367      
  **ADAMTS8-Hs00199836_m1**       0.032204915   0.2006014     0.98537743    0.010386795   0.6983311     0.012592207   
  **AMOT-Hs00611096_m1**          0.21026719    0.31007886    1.262663      0.33543622    0.6504736     0.77168876    
  **ANG;RNASE4-Hs00265741_s1**    2.2507687     1.7311066     18.238356     4.7330155     1.158861      1.4419116     
  **ANGPT1-Hs00181613_m1**        0.16360757    0.15879923    0.43314987    0.4038482     1.0788392     0.241588      
  **ANGPT2-Hs00169867_m1**        609.7327      0.12752116    4.6148005     571.9398      4.092888      540.53394     
  **CCL2-Hs00234140_m1**          0.8783502     0.7705368     2.7677026     2.3633595     1.1406118     0.93977857    
  **CD36-Hs00169627_m1**          0.26223594    0.104032315   0.3904494     0.11094416    0.32380894    0.2182351     
  **CDH5-Hs00174344_m1**          0.010893709   0.17642228    0.64253837    0.34452096    0.26403275    0.24607353    
  **CHGA-Hs00154441_m1**          647.80444                                 502.62183                   500.9494      
  **COL18A1-Hs00181017_m1**       0.93923825    0.9046015     2.5215695     1.1123142     1.0048001     1.3427103     
  **CXCL1-Hs00236937_m1**         112.537384    16.713638     234.58054     139.9429                                  
  **EDG1-Hs00173499_m1**                                      70.72058      11.466081                   13.262654     
  **EFNA2-Hs00154858_m1**                                                                 16.562565     18.947788     
  **EFNA5-Hs00157342_m1**         0.15907577    0.3788561     1.2844433     0.6810755     0.79165244    0.9987567     
  **EFNB2-Hs00187950_m1**         0.16524926    0.11053204    0.9572704     0.2282536     0.58183163    0.4981927     
  **EGF-Hs00153181_m1**           0.33341965    0.3479269     2.3004372     0.67772156    0.81617755    0.26688036    
  **EGFR-Hs00193306_m1**          3.6581511     0.79179686    2.7238734     6.1475854     0.58937544    6.7861004     
  **ENG-Hs00164438_m1**           0.13470362    0.27517623    0.8537688     0.5037209     1.0865717     0.72379035    
  **EPHB4-Hs00174752_m1**         0.36123836    0.46923497    2.6141968     0.6678707     1.0167493     0.82676744    
  **ERBB2;LEMD2-Hs00397754_m1**   0.45529452    0.43083453    1.3008044     0.7128512     0.68019813    0.7796248     
  **ETS1-Hs00428287_m1**          0.21070047    0.21789578    1.0790489     0.3943694     0.7580288     0.54431254    
  **FGF1-Hs00265254_m1**          3.4499087     2.8318844     12.711818     4.67827       1.9497786     1.498922      
  **FGF2-Hs00266645_m1**          0.3093668     0.2914567     1.3103998     0.42455202    0.5530541     0.4609033     
  **FGF7-Hs00384281_m1**          48.65966      19.154825     38.67718      518.2895      8.4551935     979.51294     
  **FGFR1-Hs00241111_m1**         0.3395128     0.3969545     1.2806027     0.48343667    0.6041856     0.6130072     
  **FGFR2-Hs00240792_m1**         0.010584445   0.09899647    0.89178413    0.004572303   0.5568605     0.006664489   
  **FGFR3-Hs00179829_m1**         0.5357339     0.48000842    8.065524      1.1046512     0.70578426    0.27442563    
  **FGFR4-Hs00242558_m1**         0.009197846   0.45745876    3.604345      0.09207129    0.52055645    0.058838986   
  **FIGF-Hs00189521_m1**          0.6024093     1.0161419     1.9958794     0.40206885    0.2503804     0.003528847   
  **FLT1-Hs00176573_m1**          4.551344      1.6045651     10.260301     53.115604     2.5825722     65.7581       
  **FLT4-Hs01047679_m1**                                      35.10392                                  17.77765      
  **FN1-Hs00415006_m1**           0.8966703     1.0181764     4.5080233     3.212114      1.1104013     2.1068652     
  **HGF-Hs00300159_m1**           0.014922882   0.55347687    2.7260602     0.019646      1.1644697     0.05273539    
  **HIF1A-Hs00153153_m1**         0.12633125    0.2151466     1.1821109     0.1177659     0.7790458     0.045135695   
  **HPSE-Hs00180737_m1**          2.0230112     5.3897333     2.5039659     3.5169048     1.5538273     3.7573454     
  **ID1-Hs00357821_g1**           1.0472269     1.8223221     6.7548165     2.972951      3.8188794     2.4504051     
  **ID3-Hs00171409_m1**           0.32124498    0.8318075     3.88177       1.9506061     2.4086914     2.0135813     
  **IFNA1-Hs00256882_s1**         10.10777      2.7188652     13.405374     5.995228      0.023557074   0.1658005     
  **IFNB1-Hs00277188_s1**         368.30457     0.729463      12.819832     416.32068     0.28179726    453.32138     
  **IGF1-Hs00153126_m1**          0.21484588    0.3462328     3.4000778     0.29004368    0.4257926     0.52136433    
  **IGF1R-Hs00181385_m1**         2.1515427     1.0385847     0.76515245    1.4102758     0.69486284    0.96284115    
  **IL10-Hs00174086_m1**          227.60149                                 462.6578                    557.3716      
  **IL12A-Hs00168405_m1**         2.6283464     0.9348713     1.9204093     1.8695375     0.65269613    0.5120319     
  **IL8-Hs00174103_m1**           8230.462      192.26549     423.45438     8035.3813     8.580302      8473.69       
  **ITGA5-Hs00233743_m1**         0.007016879   0.75174636    2.4165378     0.00529407    0.98316264    0.003165355   
  **ITGAV-Hs00233808_m1**         0.13461478    0.5350225     1.4962689     0.23020528    1.0602286     8.66E-05      
  **ITGB3-Hs00173978_m1**         3.267746      0.6539382     5.947081      1.5690391     0.98394024    0.5260183     
  **MDK-Hs00171064_m1**           3.53E-05      0.09003861    0.49126297    1.14E-05      0.4143062     1.38E-05      
  **MMP2-Hs00234422_m1**          0.06501684    0.06270294    0.5394068     0.1453691     0.36595687    0.38970318    
  **MMP9-Hs00234579_m1**          114.92867     17.523115                                                             
  **NRP1-Hs00826129_m1**          0.19253285    0.40364856    1.4642727     0.42421708    0.84969026    0.59561455    
  **PDGFA-Hs00234994_m1**         0.07274194    0.17418255    1.0910153     0.2597842     0.55965406    0.61415255    
  **PDGFB-Hs00234042_m1**         5.449627      0.10644139    6.0685534     13.468367     0.10098915    5.118809      
  **PDGFRA-Hs00183486_m1**        0.002768794   0.14088596    0.7029478     0.002547684   0.3676712     2.49E-05      
  **PDGFRB-Hs00182163_m1**        1.8774015     1.4805268     4.7943697     2.2710285     1.3572775     1.9019116     
  **PECAM1-Hs00169777_m1**        1.156894      0.052995175   0.1040989     1.2125528     0.43434724    0.5361058     
  **PGF-Hs00182176_m1**           4.7456913     2.105821      13.548447     3.155535      0.5660453     2.1796145     
  **PLAU-Hs00170182_m1**          39.47042      1.2292311     6.001818      33.187466     1.4448216     4.6638436     
  **PRL-Hs00168730_m1**           0.040201306   0.5173613     1.6739624     0.15236753    0.7588621     0.2555378     
  **PTGS1-Hs00168776_m1**         0.17535609    0.6162363     1.9374701     0.615602      0.8635668     0.5756517     
  **PTGS2-Hs00153133_m1**         24.201122     2.8172312     10.063408     32.12976      3.3911622     64.61255      
  **PTN-Hs00383235_m1**           0.057041302   0.043589298   0.085622855   0.8762439     0.041356523   0.0223033     
  **SERPINF1-Hs00171467_m1**      0.12181992    0.08697449    0.9299786     0.25972065    0.33273664    0.3643281     
  **SMAD1-Hs00195432_m1**         0.23978347    0.13695763    0.84550935    3.3624253     0.29112205    6.453879      
  **SPARC-Hs00277762_m1**         0.25483707    0.55343443    2.253073      0.64047915    1.2052313     1.3904755     
  **TGFA-Hs00177401_m1**          40.00497                                  24.532866     7.7403984     10.875058     
  **TGFB1-Hs00171257_m1**         0.6503394     0.44452885    2.2072735     1.0494986     0.9388509     0.7896068     
  **TGFB2-Hs00234244_m1**         2.218452      0.6928026     6.918003      2.7012732     1.2703435     1.6092899     
  **TGFB3-Hs00234245_m1**         0.75393504    0.29044622    2.5425553     0.6822029     0.43157336    0.5866003     
  **TGFBR1-Hs00610319_m1**        0.46907866    0.2305708     1.3967971     0.52385163    0.7293241     0.43068817    
  **TGFBR2-Hs00234253_m1**        0.6404681     0.48714763    2.9209936     1.1104643     0.899445      2.5526967     
  **TGFBR3-Hs00234257_m1**        0.10452269    0.37017035    2.3282375     0.081267394   0.65085036    0.08022497    
  **THBS1-Hs00170236_m1**         1.55E-04      0.259202      0.8546768     4.84E-04      0.30595258    6.04E-05      
  **THBS2-Hs00170248_m1**         0.8302957     0.42941177    1.9231178     0.6317223     1.504475      1.0725803     
  **THBS3-Hs00200157_m1**         0.1270221     0.002783489   2.011256      0.90325826    1.1349365     0.8794436     
  **THBS4-Hs00170261_m1**         0.78752697    0.75311714    1.391818      0.92521054    0.32537183    2.5175822     
  **TIE1-Hs00178500_m1**                        17.37359                    17.331173     16.974987     12.861118     
  **TIMP1-Hs00171558_m1**         1.2104434     1.0380837     5.269796      4.445382      0.98651147    0.6582526     
  **TIMP2-Hs00234278_m1**         0.29948968    0.39467868    2.031099      0.6166805     0.7404024     0.8702866     
  **TNF-Hs00174128_m1**           0.8617454     0.9161413     2.3081508     0.6162013     0.37398857    0.3287523     
  **TNFSF15-Hs00353710_s1**       20.48558      3.6079066     18.942228     9.134732      0.49127337    0.74366426    
  **VEGF-Hs00173626_m1**          1.56884       1.7600665     5.6470356     1.4351221     0.10570879    0.50813204    
  **VEGFB-Hs00173634_m1**         0.26353717    0.59786856    1.6840489     0.31063688    0.8122045     0.28514466    
  **VEGFC-Hs00153458_m1**         7599.6533     17.820337                   8554.023                    6385.3613     
